Consistent with such findings, our results revealed significantly higher CBFB expression in the metastatic breast cancer cell lines MDA-MB-157 and MDA-MB-436 than in the less metastatic MCF12A and T47D cells; moreover, increased CBFB levels positively correlated with poor prognosis in patients with TNBC (Figure 1). The gene discussed is CBFB; the disease is breast carcinoma.